Overcoming Antimicrobial Resistance of the Skin
The growth of AMR and recent emergence of novel infectious diseases have been exacerbated by antimicrobial overuse in humans, livestock, and agriculture. The possible overuse of antimicrobials due to the COVID-19 pandemic is also a cause for concern. Dermatologists, in particular, treat many skin conditions that warrant the utilization of antimicrobials. Consequently, dermatologists should be aware of local resistance development patterns and lower the risk of AMR by using directed therapy for the appropriate microbe, adjusting drug dosages to an effective level, prescribing antimicrobials judiciously, and providing education on AMR. It is imperative that dermatologists have an understanding of emerging infectious diseases and resistance development to effectively treat patients and combat AMR that has emerged in recent years.
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.